Pharmaceutical Technology - May 2023

Pharmaceutical Technology - May 2023

Issue link: https://www.e-digitaleditions.com/i/1499609

Contents of this Issue

Navigation

Page 14 of 36

732-658-4267 bd@ascendiapharma.com www.ascendiapharma.com Ascendia Pharma's combination of proprietary nanotechnologies and their BEST culture philosophy makes us a Partner of Choice for people with projects from complex formulations to commercial supply needs. Technical Services from Ascendia: • Rapid Early-stage Development Services • Poorly Soluble & Low Bioavailability Drug Formulations • LNP's for Vaccines, mRNA & Gene Therapy. • cGMP Sterile & Non-sterile Clinical Trial Materials • Sophisticated Formulations (Biologics & Small Molecules) • 505(b)(2) Product Development Contact Ascendia to find out how we can Make the Impossible Possible for you! From pre-formulation to Phase III and commercial supply, Ascendia is the CDMO Partner of Choice for your most challenging projects. Start your project within weeks; not months.

Articles in this issue

Links on this page

Archives of this issue

view archives of Pharmaceutical Technology - May 2023 - Pharmaceutical Technology - May 2023